Liang Qiufeng,Liang Hongwei,Hong Jiakun,Liu Xiaobing,Magnesium valproate sustained release tablets induced pancytopenia: a case report[J].SICHUAN MENTAL HEALTH,2019,32(6):562-563

Magnesium valproate sustained release tablets induced pancytopenia: a case report

DOI：10.11886/scjsws20190525002

English keywords:Magnesium valproate Pancytopenia

Fund projects:

Author Name	Affiliation
Liang Qiufeng	Clinical Department of 303th Hospital of the People's Liberation Army, Guigang 537105, China
Liang Hongwei	Clinical Department of 303th Hospital of the People's Liberation Army, Guigang 537105, China
Hong Jiakun	Clinical Department of 303th Hospital of the People's Liberation Army, Guigang 537105, China
Liu Xiaobing	Clinical Department of 303th Hospital of the People's Liberation Army, Guigang 537105, China

Hits:

Download times:

English abstract:

Magnesium valproate has been shown to be clinically effective in the treatment of various types of epilepsy and is an FDA approved drug for bipolar disorder.Clinical reactions of valproate varied greatly among individuals. Digestive tract dysfunction and liver dysfunction were common adverse reactions of magnesium valproate sustained release tablets, while pancytopenia caused by valproate was rarely reported. This paper reported a case of pancytopenia induced by magnesium valproate sustained release tablet, which arouse widespread attention in clinical.

View Full Text View/Add Comment Download reader